Daniels Mark 4
4 · Twist Bioscience Corp · Filed Mar 3, 2021
Insider Transaction Report
Form 4
Daniels Mark
Chief Compliance Officer & GC
Transactions
- Exercise/Conversion
Common Stock
2021-03-01$26.66/sh+1,166$31,086→ 68,092 total - Exercise/Conversion
Common Stock
2021-03-01$8.82/sh+377$3,325→ 68,469 total - Sale
Common Stock
2021-03-01$140.78/sh−1,543$217,224→ 66,926 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-03-01−1,166→ 37,344 totalExercise: $26.66Exp: 2028-11-18→ Common Stock (1,166 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2021-03-01−377→ 2,638 totalExercise: $8.82Exp: 2027-09-28→ Common Stock (377 underlying)
Footnotes (3)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020.
- [F2]20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- [F3]The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.